Valent BioSciences Corporation’s new $146 million biorationals manufacturing facility will supply the majority of the company’s products derived from fermentation.
Conditions seem to be coming together for a much-anticipated El Niño weather pattern, but the jury is still out on how beneficial the coming months will be for U.S. agriculture.